The mTOR/p70 S6K1 pathway regulates vascular smooth muscle cell differentiation.

Vascular smooth muscle cells (VSMC) in mature, normal blood vessels exhibit a differentiated, quiescent, contractile morphology, but injury induces a phenotypic modulation toward a proliferative, dedifferentiated, migratory phenotype with upregulated extracellular matrix protein synthesis (synthetic phenotype), which contributes to intimal hyperplasia. The mTOR (the mammalian target of rapamycin) pathway inhibitor rapamycin inhibits intimal hyperplasia in animal models and in human clinical trials. We report that rapamycin treatment induces differentiation in cultured synthetic phenotype VSMC from multiple species. VSMC treated with rapamycin assumed a contractile morphology, quantitatively reflected by a 67% decrease in cell area. Total protein and collagen synthesis were also inhibited by rapamycin. Rapamycin induced expression of the VSMC differentiation marker contractile proteins smooth muscle (SM) alpha-actin, calponin, and SM myosin heavy chain (SM-MHC), as observed by immunoblotting and immunohistochemistry. Notably, we detected a striking rapamycin induction of calponin and SM-MHC mRNA, suggesting a role for mTOR in transcriptional control of VSMC gene expression. Rapamycin also induced expression of the cyclin-dependent kinase inhibitors p21(cip) and p27(kip), consistent with cell cycle withdrawal. Rapamycin inhibits mTOR, a signaling protein that regulates protein synthesis effectors, including p70 S6K1. Overexpression of p70 S6K1 inhibited rapamycin-induced contractile protein and p21(cip) expression, suggesting that this kinase opposes VSMC differentiation. In conclusion, we report that regulation of VSMC differentiation is a novel function of the rapamycin-sensitive mTOR signaling pathway.

[1]  J. Blenis,et al.  Ribosomal S6 Kinase 2 Inhibition by a Potent C-terminal Repressor Domain Is Relieved by Mitogen-activated Protein-Extracellular Signal-regulated Kinase Kinase-regulated Phosphorylation* , 2001, The Journal of Biological Chemistry.

[2]  K. Sobue,et al.  Changes in the Balance of Phosphoinositide 3-Kinase/Protein Kinase B (Akt) and the Mitogen-activated Protein Kinases (ERK/p38MAPK) Determine a Phenotype of Visceral and Vascular Smooth Muscle Cells , 1999, The Journal of cell biology.

[3]  J. Badimón,et al.  Rapamycin inhibits vascular smooth muscle cell migration. , 1996, The Journal of clinical investigation.

[4]  M. Mann,et al.  Cell Cycle Protein Expression in Vascular Smooth Muscle Cells In Vitro and In Vivo Is Regulated Through Phosphatidylinositol 3-Kinase and Mammalian Target of Rapamycin , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[5]  K. Kinzler,et al.  A simplified system for generating recombinant adenoviruses. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[6]  A. Gingras,et al.  eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. , 1999, Annual review of biochemistry.

[7]  A. Sorisky,et al.  Rapamycin‐sensitive phase of 3T3‐L1 preadipocyte differentiation after clonal expansion , 2001, Journal of cellular physiology.

[8]  G. Schultz,et al.  Gβγ Mediate Differentiation of Vascular Smooth Muscle Cells* , 2001, The Journal of Biological Chemistry.

[9]  Benno J. Rensing,et al.  Sustained Suppression of Neointimal Proliferation by Sirolimus-Eluting Stents: One-Year Angiographic and Intravascular Ultrasound Follow-Up , 2001, Circulation.

[10]  S. Marx,et al.  Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells. , 1995, Circulation research.

[11]  B. Sumpio,et al.  Endothelial cell effect on smooth muscle cell collagen synthesis. , 1997, The Journal of surgical research.

[12]  Y. Ohkawa,et al.  Calcineurin-mediated pathway involved in the differentiated phenotype of smooth muscle cells. , 2003, Biochemical and biophysical research communications.

[13]  J. Chen,et al.  Cytoplasmic-nuclear shuttling of FKBP12-rapamycin-associated protein is involved in rapamycin-sensitive signaling and translation initiation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[14]  P. Sassone-Corsi,et al.  Positive regulation of the cAMP-responsive activator CREM by the p70 S6 kinase: An alternative route to mitogen-induced gene expression , 1994, Cell.

[15]  H. Koh,et al.  Cloning and characterization of a nuclear S6 kinase, S6 kinase-related kinase (SRK); A novel nuclear target of Akt , 1999, Oncogene.

[16]  K. Sobue,et al.  Differentiated Phenotype of Smooth Muscle Cells Depends on Signaling Pathways through Insulin-like Growth Factors and Phosphatidylinositol 3-Kinase* , 1998, The Journal of Biological Chemistry.

[17]  Y. Ohkawa,et al.  Phenotypic Modulation of Vascular Smooth Muscle Cells Induced by Unsaturated Lysophosphatidic Acids , 2001, Circulation research.

[18]  S. Marx,et al.  Role for p27(Kip1) in Vascular Smooth Muscle Cell Migration. , 2001, Circulation.

[19]  Ousa,et al.  A RANDOMIZED COMPARISON OF A SIROLIMUS-ELUTING STENT WITH A STANDARD STENT FOR CORONARY REVASCULARIZATION , 2002 .

[20]  Y. Honma,et al.  Induction of differentiation of human myeloid leukemia cells by immunosuppressant macrolides (rapamycin and FK506) and calcium/calmodulin-dependent kinase inhibitors. , 2001, Experimental hematology.

[21]  I. Gout,et al.  Molecular Cloning and Characterization of a Novel p70 S6 Kinase, p70 S6 Kinase β Containing a Proline-rich Region* , 1998, The Journal of Biological Chemistry.

[22]  K. Walsh,et al.  Transcriptional regulation of vascular smooth muscle cell phenotype , 2001, Zeitschrift für Kardiologie.

[23]  A. Skoultchi,et al.  Coordinating cell proliferation and differentiation. , 2001, Current opinion in genetics & development.

[24]  D. Brenner,et al.  5′ Stem-Loop of Collagen α1(I) mRNA Inhibits Translationin Vitro but Is Required for Triple Helical Collagen Synthesis in Vivo* , 2003, The Journal of Biological Chemistry.

[25]  K. Sobue,et al.  Expressional regulation of smooth muscle cell-specific genes in association with phenotypic modulation , 2004, Molecular and Cellular Biochemistry.

[26]  David J. Anderson,et al.  Alternative Neural Crest Cell Fates Are Instructively Promoted by TGFβ Superfamily Members , 1996, Cell.

[27]  T. McCaffrey.  TGF-s and TGF- receptors in atherosclerosis , 2000 .

[28]  K. Hirschi,et al.  PDGF, TGF-β, and Heterotypic Cell–Cell Interactions Mediate Endothelial Cell–induced Recruitment of 10T1/2 Cells and Their Differentiation to a Smooth Muscle Fate , 1998, The Journal of cell biology.

[29]  V. Fuster,et al.  Modulation of apoptosis, proliferation, and p27 expression in a porcine coronary angioplasty model. , 2000, Atherosclerosis.

[30]  S. Schreiber,et al.  Protein phosphatase 2A interacts with the 70-kDa S6 kinase and is activated by inhibition of FKBP12-rapamycinassociated protein. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Julie H. Campbell,et al.  Arterial smooth muscle. A multifunctional mesenchymal cell. , 1988, Archives of pathology & laboratory medicine.

[32]  Michael N. Hall,et al.  TOR signalling in bugs, brain and brawn , 2003, Nature Reviews Molecular Cell Biology.

[33]  S Marx,et al.  Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle. , 1999, Circulation.

[34]  Y. Yazaki,et al.  Developmentally regulated expression of vascular smooth muscle myosin heavy chain isoforms. , 1989, The Journal of biological chemistry.

[35]  T. Hayakawa,et al.  Commitment of Neutrophilic Differentiation and Proliferation of HL-60 Cells Coincides with Expression of Transferrin Receptor , 1999, The Journal of Biological Chemistry.

[36]  M. Paul,et al.  ERK1/2-Dependent Contractile Protein Expression in Vascular Smooth Muscle Cells , 2003, Hypertension.

[37]  R. Morris,et al.  EFFECTS OF RAPAMYCIN ON GROWTH FACTOR‐STIMULATED VASCULAR SMOOTH MUSCLE CELL DNA SYNTHESIS INHIBITION OF BASIC FIBROBLAST GROWTH FACTOR AND PLATELET‐DERIVED GROWTH FACTOR ACTION AND ANTAGONISM OF RAPAMYCIN BY FK506 , 1995, Transplantation.

[38]  M. Fillinger,et al.  Coculture of endothelial cells and smooth muscle cells in bilayer and conditioned media models. , 1997, The Journal of surgical research.

[39]  A. Mahfoudi,et al.  p21CIP1-mediated inhibition of cell proliferation by overexpression of the gax homeodomain gene. , 1997, Genes & development.

[40]  T. McCaffrey.  TGF-betas and TGF-beta receptors in atherosclerosis. , 2000, Cytokine & growth factor reviews.

[41]  G. Owens,et al.  CArG elements control smooth muscle subtype-specific expression of smooth muscle myosin in vivo. , 2001, The Journal of clinical investigation.

[42]  J. Blenis,et al.  Coordinate regulation of translation by the PI 3-kinase and mTOR pathways. , 2002, Advances in cancer research.

[43]  J. Ju,et al.  Immunosuppressant rapamycin inhibits protein kinase C alpha and p38 mitogen-activated protein kinase leading to the inhibition of chondrogenesis. , 2001, European journal of pharmacology.

[44]  O. Schweikart,et al.  Standardisierte Befunderfassung in der Echokardiographie mittels WWW: EchoBefundSystem , 2001, Zeitschrift für Kardiologie.

[45]  J. Pouysségur,et al.  p70 S6 Kinase-mediated Protein Synthesis Is a Critical Step for Vascular Endothelial Cell Proliferation* , 1999, The Journal of Biological Chemistry.